View in EDS HTML Full Text PDF Full Text

Overall survival with momelotinib vs. best available therapy in patients with ruxolitinib-experienced myelofibrosis: a matching-adjusted indirect comparison.

Saved in:
Bibliographic Details
Title: Overall survival with momelotinib vs. best available therapy in patients with ruxolitinib-experienced myelofibrosis: a matching-adjusted indirect comparison.
Authors: Palandri F; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy. francesca.palandri@unibo.it., Kapetanakis V; Evidera, London, UK., Dobi B; Evidera, Budapest, Hungary., Breccia M; Department of Translational and Precision Medicine, Azienda Policlinico Umberto I, Sapienza University, Roma, Italy., Palumbo GA; Department of Scienze Mediche, Chirurgiche e Tecnologie Avanzate 'G.F. Ingrassia', University of Catania, Catania, Italy., Abruzzese E; S Eugenio Hospital, ASL Roma 2, Tor Vergata University, Roma, Italy., Bonifacio M; Department of Engineering for Innovation Medicine, Section of Innovation Biomedicine, University of Verona, Verona, Italy., Tiribelli M; Division of Hematology and BMT, ASUFC and Department of Medicine, University of Udine, Udine, Italy., Elli EM; Hematology Division and Bone Marrow Unit, Fondazione IRCCS, San Gerardo dei Tintori, Monza, Italy., Morsia E; Hematology Unit, Department of Clinical and Molecular Sciences, DISCLIMO, Università Politecnica delle Marche, Ancona, Italy., Branzanti F; Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy., Ellis CE; GSK plc, Collegeville, PA, USA., Ballew N; GSK plc, Collegeville, PA, USA., Liu T; GSK plc, Collegeville, PA, USA., Phiri K; GSK plc, Collegeville, PA, USA., Sen Nikitas F; GSK plc, London, UK., Zhang S; GSK plc, Collegeville, PA, USA., Patnaik D; GSK plc, Baar, Switzerland.
Source: Annals of hematology [Ann Hematol] 2026 Feb 21; Vol. 105 (4). Date of Electronic Publication: 2026 Feb 21.
Publication Type: Journal Article; Comparative Study
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41721879
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Overall survival with momelotinib vs. best available therapy in patients with ruxolitinib-experienced myelofibrosis: a matching-adjusted indirect comparison.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Palandri+F%22">Palandri F</searchLink>; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy. francesca.palandri@unibo.it.<br /><searchLink fieldCode="AU" term="%22Kapetanakis+V%22">Kapetanakis V</searchLink>; Evidera, London, UK.<br /><searchLink fieldCode="AU" term="%22Dobi+B%22">Dobi B</searchLink>; Evidera, Budapest, Hungary.<br /><searchLink fieldCode="AU" term="%22Breccia+M%22">Breccia M</searchLink>; Department of Translational and Precision Medicine, Azienda Policlinico Umberto I, Sapienza University, Roma, Italy.<br /><searchLink fieldCode="AU" term="%22Palumbo+GA%22">Palumbo GA</searchLink>; Department of Scienze Mediche, Chirurgiche e Tecnologie Avanzate 'G.F. Ingrassia', University of Catania, Catania, Italy.<br /><searchLink fieldCode="AU" term="%22Abruzzese+E%22">Abruzzese E</searchLink>; S Eugenio Hospital, ASL Roma 2, Tor Vergata University, Roma, Italy.<br /><searchLink fieldCode="AU" term="%22Bonifacio+M%22">Bonifacio M</searchLink>; Department of Engineering for Innovation Medicine, Section of Innovation Biomedicine, University of Verona, Verona, Italy.<br /><searchLink fieldCode="AU" term="%22Tiribelli+M%22">Tiribelli M</searchLink>; Division of Hematology and BMT, ASUFC and Department of Medicine, University of Udine, Udine, Italy.<br /><searchLink fieldCode="AU" term="%22Elli+EM%22">Elli EM</searchLink>; Hematology Division and Bone Marrow Unit, Fondazione IRCCS, San Gerardo dei Tintori, Monza, Italy.<br /><searchLink fieldCode="AU" term="%22Morsia+E%22">Morsia E</searchLink>; Hematology Unit, Department of Clinical and Molecular Sciences, DISCLIMO, Università Politecnica delle Marche, Ancona, Italy.<br /><searchLink fieldCode="AU" term="%22Branzanti+F%22">Branzanti F</searchLink>; Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy.<br /><searchLink fieldCode="AU" term="%22Ellis+CE%22">Ellis CE</searchLink>; GSK plc, Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Ballew+N%22">Ballew N</searchLink>; GSK plc, Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Liu+T%22">Liu T</searchLink>; GSK plc, Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Phiri+K%22">Phiri K</searchLink>; GSK plc, Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Sen+Nikitas+F%22">Sen Nikitas F</searchLink>; GSK plc, London, UK.<br /><searchLink fieldCode="AU" term="%22Zhang+S%22">Zhang S</searchLink>; GSK plc, Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Patnaik+D%22">Patnaik D</searchLink>; GSK plc, Baar, Switzerland.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229107334%22">Annals of hematology</searchLink> [Ann Hematol] 2026 Feb 21; Vol. 105 (4). <i>Date of Electronic Publication: </i>2026 Feb 21.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Comparative Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Verlag%22">Springer Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>9107334 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-0584 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209395555%22">09395555 </searchLink><i>NLM ISO Abbreviation: </i>Ann Hematol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41721879
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s00277-026-06873-w
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Overall survival with momelotinib vs. best available therapy in patients with ruxolitinib-experienced myelofibrosis: a matching-adjusted indirect comparison.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Palandri F
      – PersonEntity:
          Name:
            NameFull: Kapetanakis V
      – PersonEntity:
          Name:
            NameFull: Dobi B
      – PersonEntity:
          Name:
            NameFull: Breccia M
      – PersonEntity:
          Name:
            NameFull: Palumbo GA
      – PersonEntity:
          Name:
            NameFull: Abruzzese E
      – PersonEntity:
          Name:
            NameFull: Bonifacio M
      – PersonEntity:
          Name:
            NameFull: Tiribelli M
      – PersonEntity:
          Name:
            NameFull: Elli EM
      – PersonEntity:
          Name:
            NameFull: Morsia E
      – PersonEntity:
          Name:
            NameFull: Branzanti F
      – PersonEntity:
          Name:
            NameFull: Ellis CE
      – PersonEntity:
          Name:
            NameFull: Ballew N
      – PersonEntity:
          Name:
            NameFull: Liu T
      – PersonEntity:
          Name:
            NameFull: Phiri K
      – PersonEntity:
          Name:
            NameFull: Sen Nikitas F
      – PersonEntity:
          Name:
            NameFull: Zhang S
      – PersonEntity:
          Name:
            NameFull: Patnaik D
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 21
              M: 02
              Text: 2026 Feb 21
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1432-0584
          Numbering:
            – Type: volume
              Value: 105
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Annals of hematology
              Type: main
ResultId 1